Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.09M Sell
40,006
-4,498
-10% -$968K 0.28% 95
2026
Q1
$9.68M Hold
44,504
1.29% 10
2025
Q4
$10.2M Buy
44,504
+9,982
+29% +$2.27M 1.24% 10
2025
Q3
$7.99M Sell
34,522
-7,178
-17% -$1.46M 0.95% 19
2025
Q2
$7.74M Sell
41,700
-12,161
-23% -$2.26M 0.87% 21
2025
Q1
$11.3M Hold
53,861
1.23% 16
2024
Q4
$9.57M Sell
53,861
-6,996
-11% -$1.29M 0.98% 17
2024
Q3
$2.98M Hold
60,857
0.32% 85
2024
Q2
$10.4M Buy
+60,857
New +$10.1M 1% 15

Other funds holding ABBV

BDF Gestion's ABBV Position: Q2 2026 in Review

BDF Gestion reduced its AbbVie (ABBV) stake by 10% in Q2 2026, selling an estimated $968K and leaving 40,006 shares worth $2.09M. The position accounts for 0.28% of the portfolio, ranked #95.

BDF Gestion first reported a position in ABBV in Q2 2024 and has held it in 9 quarters since. The position peaked at $11.3M in Q1 2025. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • BDF Gestion held 40,006 shares of AbbVie worth $2.09M as of Q2 2026.
  • BDF Gestion sold 4,498 AbbVie shares in Q2 2026, an estimated $968K.
  • AbbVie made up 0.28% of BDF Gestion's portfolio in Q2 2026, its #95 holding.
  • BDF Gestion first reported a position in AbbVie in Q2 2024 and has held it in 9 quarters since.
  • BDF Gestion's AbbVie position peaked at $11.3M in Q1 2025.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on BDF Gestion's 13F filing for Q2 2026, filed 7 Jul 2026.